Nature's Miracle Holding Inc. NMHI
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $1.1M
- P/E
- 0.0×
Follow NMHI
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.94 | 0.26 | 27.40 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(0.75) | (0.89) | (283.79) | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
5.98 | 0.86 | 28.08 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(2.61) | (1.35) | (149.28) | 0.00 |
EV/FCF |
(2.60) | (1.35) | (149.28) | 0.00 |
Quick Ratio |
0.01 | 0.16 | 0.12 | 0.26 |
Current Ratio |
0.04 | 0.26 | 0.50 | 0.80 |
Net Debt/EBITDA |
(1.57) | (0.57) | (1.37) | (1.75) |
Debt/Assets |
43.45% | 52.86% | 44.00% | 14.76% |
Debt/Equity |
(0.70) | (0.42) | (0.93) | 4.99 |
Asset Turnover |
0.11 | 0.73 | 0.51 | 0.00 |
Operating CF/Net income |
0.33 | 0.43 | 0.23 | 1.00 |
Capex/Depreciation |
0.02 | 0.00 | 0.00 | (0.11) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| 88.53% | 129.67% | 240.50% | 0.00% | |
| (75.57%) | (107.03%) | (41.87%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% | (38.41%) |
Return on Tangible Assets |
305.04% | 131.86% | 247.35% | (187.24%) |
Average Days of Receivables |
32.05 | 110.56 | 63.00 | 69.69 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
280.25% | 77.03% | 35.36% | 18.49% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.05 |
Share Based Compensation of Revenue |
19.60% | 15.26% | 0.00% | 0.00% |
Graham Net Nets |
(19.61) | (8.37) | (0.06) | 0.00 |
Graham Number |
3.88 | 57.95 | 44.87 | 0.00 |
Earnings Yield |
(712.91%) | (561.69%) | (3.00%) | (3.00%) |
Free Cash Flow Yield |
(244.33%) | (242.43%) | (0.69%) | 0.00% |
Revenue per Share |
0.12 | 8.06 | 12.03 | 33.47 |
Operating CF per Share |
(0.27) | (5.16) | (2.26) | (4.41) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.10) |
Free Cash Flow per Share |
(0.27) | (5.16) | (2.26) | (4.50) |
Cash per Share |
0.01 | 0.37 | 0.30 | 1.46 |
Shareholders Equity per Share |
(0.85) | (12.48) | (9.05) | 1.11 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.85) | (12.48) | (9.05) | 1.11 |
Free Cash Flow |
(3.96) | (5.93) | (1.68) | (2.51) |
Working Capital |
(22.30) | (14.60) | (7.37) | (3.27) |
Capital Expenditures |
0.03 | — | — | (0.05) |
Net Current Asset Value |
(32.20) | (20.49) | (13.51) | (6.78) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
(0.01) | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
(687.93%) | (147.42%) | (82.15%) | (13.22%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||
Depreciation/Fixed assets |
0.09 | 0.15 | 0.37 | 0.10 |
Cash ROIC |
592.26% | 128.24% | 2,440.42% | (156.27%) |
Accounts Receivable Turnover |
1.18 | 4.26 | 3.51 | 0.00 |
Accounts Payable Turnover |
0.21 | 1.12 | 0.87 | 0.00 |
Inventory Turnover |
0.00 | 3.54 | 1.43 | 0.00 |
Average Days of Payables |
1,672.62 | 323.61 | 398.63 | 257.09 |
Days of Inventory on Hand |
0.00 | 53.80 | 186.39 | 189.52 |
Average Receivables |
1.48 | 2.17 | 2.55 | — |
Average Payables |
10.37 | 10.75 | 11.37 | — |
Average Inventory |
— | 3.41 | 6.92 | — |
Average Assets |
15.86 | 12.76 | 17.52 | — |
Average Common Equity |
(13.54) | (10.53) | (3.05) | — |
Columns are period end dates